Literature DB >> 5138448

Estrogen inhibition of mammary tumor growth in rats; counteraction by prolactin.

J Meites, E Cassell, J Clark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5138448     DOI： 10.3181/00379727-137-35760

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  7 in total

1.  Exposure to the Endocrine Disruptor Bisphenol A Alters Susceptibility for Mammary Cancer.

Authors:  Coral A Lamartiniere; Sarah Jenkins; Angela M Betancourt; Jun Wang; Jose Russo
Journal:  Horm Mol Biol Clin Investig       Date:  2011-03-01

2.  Proceedings of the British Pharmacological Society. 11th-13th April, 1984. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

3.  Hypothesis: breast cancer regression under oestrogen therapy.

Authors:  B A Stoll
Journal:  Br Med J       Date:  1973-08-25

Review 4.  Relation of the neuroendocrine system to the development and growth of experimental mammary tumors.

Authors:  J Meites
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

5.  Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen.

Authors:  N Shigaki; M Kimura; S Takano; N Fujino; M Akagi
Journal:  Jpn J Surg       Date:  1987-09

6.  Influence of hormones on DNA synthesis of breast tumors in culture.

Authors:  G Calaf; F Garrido; C Moyano; R Rodríguez
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

7.  Inhibition of mammary tumors by pretreatment with 17 beta-estradiol in F344 rats induced with N-methyl-N-nitrosourea.

Authors:  A Ito; T Okamoto; N Fujimoto; P O Ogundigie; H Watanabe
Journal:  Jpn J Cancer Res       Date:  1994-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.